Last reviewed · How we verify
NCT05832840: PREPSA
Survey Tool for Screening of Anemia in Women Before Pregnancy
trial in Anemia Complicating Pregnancy in 503 participants. Completed in 4 July 2023.
13 June 2023
Quick facts
| Lead sponsor | NICHD Global Network for Women's and Children's Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 503 |
| Start date | 17 April 2023 |
| Primary completion | 13 June 2023 |
| Estimated completion | 4 July 2023 |
| Sites | 1 location across India |
Conditions studied
- Anemia Complicating Pregnancy — all drugs for Anemia Complicating Pregnancy →
- Anemia Complicating Childbirth — all drugs for Anemia Complicating Childbirth →
- Anemia Complicating the Puerperium — all drugs for Anemia Complicating the Puerperium →
Sponsor
NICHD Global Network for Women's and Children's Health
Who can join
Adults 18 to 25, female only, with Anemia Complicating Pregnancy or Anemia Complicating Childbirth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational and cross-sectional study is to develop and validate a survey that can be used to identify anemia, and its severity, among pre-pregnant women allowing for the timely implementation of focused public health and personalized interventions. Participants will be asked 26 survey questions about menstrual history and provide a 5 ml venous blood sample to measure hemoglobin, ferritin, and transferrin saturation levels.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05832840
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other NICHD Global Network for Women's and Children's Health trials
Trials by the same sponsor.
- NCT05590260 — Prevention of Iron Deficiency Anemia Post-delivery · Phase 3 · unknown
- NCT05946681 — Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings · completed
- NCT04888377 — ASPIRIN: Neurodevelopmental Follow-up Trial · completed
- NCT03871491 — Azithromycin-Prevention in Labor Use Study (A-PLUS) · Phase 3 · completed
- NCT02409680 — Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05832840 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NICHD Global Network for Women's and Children's Health
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05832840.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing